MMDA (psychedelic)



MMDA
Chemical name 3-methoxy-4,5-Methylenedioxyamphetamine
or
1-(7-methoxy-1,3-benzodioxol-5-yl)propan-2-amine
Chemical formula O3
Molecular mass 209.2417 g/mol
Melting point 133-134 °C (hydrochloride)
CAS numbers 13674-05-0
SMILES CC(N)Cc1cc2OCOc2c(c1)OC

MMDA, or 3-methoxy-4,5-methylenedimyristicin found in nutmeg. MMDA is most typically taken orally (as pressed tablets) or intranasally (as a powder).

MMDA was written up by Side effects include moderate mydriasis, dizziness, sensations of heat or cold, and trembling. The imagery is generally realistic, and often related to everyday perception of people, landscapes, or objects. The effects of MMDA usually reach a peak after the first hour following the initial symptoms, and begin to wane during the second hour, and usually completely disappear by the end of the fifth hour.

Analogs

           

MMDA-2

Dosage: 25-50 mgs

Duration: 8-12 hours

Effects: slow, MDA-like effects, muscle stiffness, inability to defecate

Methyl-MMDA-2

Dosage: unknown

Duration: unknown

Effects: Few to none

MMDA-3a

Dosage: 20-80 mgs

Duration: 10-16 hours

Effects: mild open-eye visuals, visual enhancement of music, slowing of time, slight diarrhea and body load

MMDA-3b

Dosage: unknown

Duration: unknown

Effects: Few to none

2T-MMDA-3a

Dosage: unknown

Duration: unknown

Effects: Few to none

4T-MMDA-2

Dosage: 25 mg

Duration: unknown

Effects: Slight tremors

Psychotherapuetic actions

In his 1973 book, "The Healing Journey," Claudio Naranjo explored the psychotherapeutic potential of MMDA. Like MDA, he found that MMDA facilitates communication and suggested it has potential applications in psychotherapy. Worldwide as of 2005, MMDA has not been approved for any human applications.

Pharmacology

The mechanism that produces the psychedelic activity of MMDA has not been definitively established. There are, as of the present time, no reported studies on the human MDMA.

Legality

MMDA is classified as a Schedule 1 substance in the United States, and is similarly controlled in other parts of the world. Internationally, MMDA is a Schedule I drug under the Convention on Psychotropic Substances[1].

See also


v • d • e
Methylenedioxyphenethylamines

DMMDA · DMMDA-2 · EBDB · Ethyl-K · BDB · bk-MDEA · bk-MBDB · Lophophine · Madam-6 · MDA · MDAL · MDBU · MDBZ · MDCPM · MDDM · MDEA · MDHOET · MDIP · MDMA · MDMEO · MDMEOET · MDMP · MDOH · MDPEA · MDPH · MDPL · MDPR · MBDB · Methyl-K · Methylone · MMDA · MMDMA ·

v • d • e
Empathogen-entactogens -

5-MeO-DALT | α-ET | bk-MBDB | bk-MDEA | bk-MDMA | DMMDA-2 | IAP | MBDB | MDA | MDEA | MDMA | MMDA

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "MMDA_(psychedelic)". A list of authors is available in Wikipedia.